Modafinil treatment of opioid-induced sedation.
The purpose of this study was to assess the efficacy of modafinil in combating opioid-induced sedation. A 1-year retrospective chart review of all patients receiving modafinil, a wake-promoting agent, to treat opioid-induced sedation. Opioid-induced sedation was measured using Epworth Sleepiness Scale (ESS). Outpatient, private practice. Eleven adult patients, six female and five male, being treated with opioids for chronic, nonmalignant pain. A significant decrease was observed between pretreatment and posttreatment ESS measurements during modafinil treatment. The results suggest an improvement in opioid-induced sedation in patients treated for nonmalignant pain.